Advertisements

Panthoderm Cream

Quick links to important sections

Panthoderm Cream

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Panthoderm Cream

Quick Facts

Property Description
Active Ingredient Dexpanthenol (Provitamin B5), Emollients Topical
Form Cream (Topical preparation)
Pharmacological Class Miscellaneous Topical Agent, Vitamin B Complex Analogue
General Purpose Skin Protectant, Barrier Support
Origin Derived (Synthetic analogue of Pantothenic Acid)

What Type of Medicine is Panthoderm Cream?

Panthoderm Cream is a pharmaceutical topical preparation classified broadly as a miscellaneous topical agent and a Vitamin B complex analogue. This combination product is designed for exclusive dermal use in the form of a cream, ensuring its action remains localized to the skin's surface. Dexpanthenol formulations are clinically recognized for their efficacy in low-irritation skin care, making them commonly positioned for sensitive populations. The product's fundamental identity as an over-the-counter (OTC) preparation makes it broadly accessible for immediate management of common surface skin issues.

Composition and Origin: Dexpanthenol and Topical Emollients

The composition of Panthoderm Cream is centered on Dexpanthenol and various topical emollients, suspended within a moisturizing cream base. Dexpanthenol is a derived substance, functioning as a Provitamin B5 that readily converts into functional pantothenic acid upon absorption by the skin cells. This conversion is necessary for the synthesis of Coenzyme A, a key factor in cellular repair. This composition distinguishes it as a preparation intended not only for physical moisture retention but also for active epithelial support.

What is the General Purpose of Panthoderm Cream?

The general purpose of Panthoderm Cream is to serve as a skin protectant providing support for dry skin conditions and promoting structural integrity. The topical emollients ensure rapid softening of the skin and reduction of water loss, while the Dexpanthenol provides deep epithelial support. This combination enables the preparation to effectively assist the natural restorative processes of the skin, offering relief from common minor discomfort. A typical, neutral use scenario involves applying the cream to address minor chafing or general skin dryness to support the natural healing response.

Advertisements

What side effects are possible with Panthoderm Cream?

Possible Side Effects and Safety Information

The safety profile for topical dexpanthenol preparations, such as Panthoderm Cream, is defined by officially documented adverse events grouped under System-Organ Classes. These include Skin and Subcutaneous Tissue Disorders and, critically, Immune System Disorders.

Adverse Reactions Classification

The frequency of most localized adverse reactions is often Not Defined in official regulatory documents, though they are generally considered common when they occur. Serious adverse events, however, are typically described as rare.

Adverse Reaction Type Classification / System-Organ Class
Common/Expected Dermal Effects Rash, itching (pruritus), hives (urticaria), tingling, or localized irritation. (Skin and Subcutaneous Tissue Disorders)
Serious Adverse Reactions Signs of a Hypersensitivity reaction (allergic reaction), including swelling of the face, throat, or tongue, and difficulty breathing or swallowing. (Immune System and Respiratory Disorders)

Safety Restrictions and Population-Specific Notes

The most important safety restriction is a contraindication against use in any individual with a known hypersensitivity or allergy to dexpanthenol or any other component in the cream. Panthoderm Cream is strictly for external use only, as noted in the regulatory labeling.

Official safety notes require caution for specific patient groups. Regulatory documents align the medicine with Pregnancy Category C, suggesting use only when the potential benefit outweighs the potential risk. Caution is also advised during lactation (breast-feeding), where thorough cleansing of the area is required if applied to the nipple.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information regarding Panthoderm Cream (Dexpanthenol) is based on the extremely low toxicity profile of its active ingredient. Regulatory authorities, including the NIH, have not established a Tolerable Upper Intake Level (UL) for pantothenic acid due to the lack of documented severe adverse effects in humans, indicating that the risk of overdose from topical application is negligible.


Documented Manifestations and Emergency Action

Overdose Context Official Regulatory Finding
Documented Manifestations Diarrhea and gastrointestinal distress are the only manifestations documented, occurring only after massive, supra-therapeutic oral ingestion of the active substance.
Antidote Information No specific antidote is known; management is restricted to symptomatic and supportive treatment.
Emergency Actions Regulatory labeling explicitly requires users to seek medical help or contact a Poison Control Center right away if the product is swallowed (accidental ingestion).

Overdose from intended topical use is not associated with severe or life-threatening outcomes. The immediate action mandated by regulators is triggered by the accidental swallowing of the cream, which necessitates professional evaluation for symptomatic relief.

Advertisements

Therapeutic Uses of Panthoderm Cream

What Panthoderm Cream Treats: Main Uses and Benefits

Panthoderm Cream is commonly used to offer supportive relief and structural maintenance for the skin barrier across common dermatological challenges, focusing exclusively on symptom management and skin surface stability. Its therapeutic relevance is associated with easing itching and contributing to the support of skin lesions and dermatoses.


Easing Acute Symptoms and Supporting Barrier Function

The cream is commonly used to address the symptom cluster of roughness, scaling, and dryness in conditions such as xerosis and the maintenance phases of mild to moderate Atopic Dermatitis (eczema). It is also applied in situations involving minor skin irritations, including chafing and mild sunburn, as well as for superficial wounds and lesions. This assistance may be part of symptomatic management across domains where additional symptomatic support is needed.

This therapeutic assistance is often applied in situations requiring gentle symptomatic relief for specific patient groups, including infants with diaper dermatitis or breastfeeding individuals managing nipple discomfort. It helps address symptom clusters that may become intense or disruptive, contributing to day-to-day comfort and assisting with maintaining functional stability of the skin barrier.

Quick Fact: Relief for Dryness and Irritation
Symptom Domain Chronic Dryness, Acute Surface Irritation, Superficial Trauma
Conditions Used In Xerosis, Minor Burns, Diaper Dermatitis, Mild Eczema
Core Benefit Supportive Relief, Epithelial Repair Assistance, Barrier Stabilization
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Panthoderm Cream?

The population eligibility for Panthoderm Cream is strictly governed by regulatory documentation, which defines both allowed groups and absolute exclusions.

Eligibility Scope

Scope Detail
Populations for whom use is allowed General adult population for skin protection; use is officially established for the infant/pediatric population for labeled uses, such as diaper rash.
Populations for whom use is contraindicated Individuals with known hypersensitivity or allergy to the active ingredient dexpanthenol or any other excipients in the cream formulation.
Age-related eligibility rules No specific lower age limit is cited as a contraindication, and no restrictions are documented for the older adult population.
Condition-specific eligibility rules No explicit contraindications related to severe hepatic or renal impairment are documented for this topical formulation.
Pregnancy and lactation eligibility status Use during pregnancy is classified as conditional, indicating application with caution. Use during lactation is permitted but requires caution, as excretion into human milk is possible.

Connection to the Overall Eligibility Profile

The official regulatory profile is structured around a single absolute exclusion, which is hypersensitivity to the ingredients. Beyond this primary contraindication, eligibility is broad across the lifespan, including established use for infants. Regulatory constraints focus on conditional use for pregnant and breastfeeding individuals, for whom caution is required.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Panthoderm Cream (Dexpanthenol topical) consistently defines its interaction profile as one with minimal potential for drug interactions, which is characteristic of topical agents with low systemic absorption. Authoritative government documents, such as the Summary of Product Characteristics (SmPC) for the topical formulation, explicitly state that no drug interactions have been reported upon its use.

Documented Interaction Context

While the topical cream is generally considered to have no reported interactions, the regulatory labeling for the related parenteral (injectable) formulation of Dexpanthenol documents a significant pharmacodynamic interaction.

Classification Official Regulatory Stated Context
Interacting Medicine Succinylcholine
Effect Potentiation of the action of this neuromuscular blocker
Context Constraint Interaction is strictly confined to the parenteral route of administration

This distinction is crucial: the severe interaction with Succinylcholine and its associated mandatory timing separation requirement (must not be administered within one hour of Succinylcholine) apply only to the injectable form, not to Panthoderm Cream. No interactions with food, alcohol, supplements, or specific metabolic pathways (e.g., CYP enzymes) are documented for the topical product in official regulatory sources. The absence of documented interactions for the cream is consistent across international regulatory bodies.

Advertisements

Mechanism of Action

Metabolic Pathway Activation and Coenzyme A Synthesis

The core mechanism involves the active ingredient, dexpanthenol, functioning as a pro-vitamin. Upon absorption into the dermal and epidermal cells, it undergoes an enzymatic conversion process to yield pantothenic acid (vitamin B5). Pantothenic acid acts as a required precursor for the synthesis of Coenzyme A (CoA), a critical cofactor for numerous cellular metabolic reactions, including lipid and protein synthesis.

Influence on Epithelial Regeneration and Barrier Function

The resulting increase in CoA influences key metabolic reactions central to cellular renewal and differentiation. This mechanism is associated with influencing the process of re-epithelialization and the synthesis of the skin's intercellular lipid matrix, which includes essential ceramides and fatty acids. This effect contributes to the maintenance of the skin's structural integrity and barrier function.

Regulation of Inflammatory Signaling and Hydration

Beyond structural effects, the mechanism influences local signaling pathways, contributing to the regulation of mediator activity within the inflammatory cascade. Additionally, the molecule exhibits intrinsic humectant properties, binding water to the skin's stratum corneum. This combined effect influences the pathways involved in maintaining the skin's homeostatic balance and moisture retention.

Advertisements

Dosage and Administration Information

How to Use Panthoderm Cream: Official Administration Guidelines


Administration Scope

The approved and mandatory route for Panthoderm Cream, a topical Dexpanthenol preparation, is strictly dermal or cutaneous use only for external application. The standard strength is commonly available as 5% (5 grams Dexpanthenol per 100 grams cream). The official administration schedule involves applying a thin layer of the cream to the affected area, ensuring sufficient coverage without excessive buildup.

The frequency of application is intentionally flexible, based on individual need, as usage ranges from once daily to several times daily. The use pattern is supportive, allowing for both intermittent and continuous application as required.

Special Procedural Conditions

To ensure correct use, the administration requires careful adherence to site selection. Application must strictly avoid contact with sensitive surfaces, specifically the eyes and internal mucosae. The cream is applied as is, and no preparation or dilution is required for the formulation. Although the timing is not tied to meals, application should generally be performed after the area has been cleansed.

Age-Group and Specific Administration Rules

The product is generally considered suitable for all age groups. A specific procedural instruction exists for breastfeeding mothers: if the cream is applied to the breast area, it must be cleaned thoroughly before each subsequent nursing session to prevent unintentional exposure.


Connection to the overall use protocol

These official instructions define a standardized protocol that focuses on the topical route and a "thin layer" dose, followed by a flexible, as-needed frequency tied to ongoing symptomatic support. This structured administration framework guides the proper external application and situational handling of the cream.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Panthoderm Cream

This section provides a summary of the official research structure and information concerning Dexpanthenol cream, derived from regulatory and peer-reviewed scientific sources. It outlines what researchers have studied and what aspects of the evidence remain uncertain, without offering any clinical advice or interpretation.


Evidence for Barrier Function and Acute Irritation

Research examining the cream's application in the context of the skin's protective barrier function largely relies on Randomized Controlled Trials (RCTs), many of which are placebo-controlled, and controlled experimental studies. Researchers have specifically studied the cream in settings examining recovery after being intentionally irritated—for example, by using chemical agents in a laboratory setting. Studies monitored Transepidermal Water Loss (TEWL) and hydration levels in the outer skin layer. Research also included data collection related to clinical scoring of redness and irritation. However, the vast majority of studies focus on acute, short-term damage and provide limited insight into the effect profile in patient groups with severe or systemic skin barrier disorders.


Evidence for General Dry Skin and Epithelial Support

The scientific exploration of the cream's application in general dry skin (xerosis) and support for the skin's surface cells involves intermediate-term Randomized Controlled Trials and prospective comparative studies. This research has examined the cream on measurable parameters of skin hydration, water loss, and the general condition of chronically dry skin. Studies monitored TEWL scores and documented how patient-reported outcomes related to skin softness and scaling evolved over the intermediate duration of the studies. Data remains limited on the performance profile of the cream in specific, vulnerable elderly populations, and long-term data extending beyond the typical four-to-eight-week follow-up are not widely available.


Evidence for Supportive Use in Superficial Trauma and Dermatoses

The evidence base also includes research exploring the cream’s investigation as a supportive or adjuvant therapy for certain skin conditions and minor trauma. This includes clinical trials focused on patients recovering from minor dermatologic procedures and those managing mild Atopic Dermatitis (eczema). Studies evaluated outcomes related to changes in skin repair and integrity and monitored the symptom patterns when the cream was used as a supportive element in maintenance phases. The research largely examines the agent as an adjunct used alongside other established treatments, meaning the full standalone contribution of the cream in treating the underlying condition is often challenging to isolate.

Key Studies & References Use of Dexpanthenol for Atopic Dermatitis—Benefits and Recommendations Based on Current Evidence - PubMed

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Panthoderm Cream (FAQ)


Q: What are the general population contraindications for Panthoderm Cream?

A: The single absolute contraindication defined in official regulatory documents is a known hypersensitivity or allergy to the active ingredient, Dexpanthenol, or to any of the other excipients (inactive ingredients) in the cream formulation.


Q: Does Panthoderm Cream contain steroids?

A: No. Official product information classifies the active ingredient as Dexpanthenol, which is a Pro-vitamin B5 analogue. It is categorized as a miscellaneous topical agent and does not belong to the class of corticosteroids (steroids).


Q: Is Panthoderm Cream the same as other moisturizing creams?

A: The cream is classified by authorities as both a miscellaneous topical agent and a Vitamin B complex analogue because its active ingredient functions as a pro-vitamin. This mechanism, which supports cellular renewal, distinguishes it from basic moisturizing creams, whose primary role is typically limited to providing an emollient or occlusive layer.


Q: Is Panthoderm Cream described as being moisturizing or primarily protective?

A: Official information describes the cream's purpose as serving as a skin protectant and providing support for dry skin conditions. The product's mechanism involves both humectant properties, which help bind water to the skin, and the synthesis of the skin's lipid matrix, suggesting it offers both moisturizing and protective functions.


Q: How does Panthoderm Cream differ from products containing petrolatum?

A: Petrolatum is classified as a physical occlusive agent, primarily acting to create a thick barrier to prevent water loss from the skin. Panthoderm Cream’s active ingredient, Dexpanthenol, is classified as a pro-vitamin that influences skin cell repair and lipid synthesis, offering cellular support alongside an emollient effect.


Q: How often can someone generally use Panthoderm Cream?

A: Official administration schedules often describe the frequency of use as flexible, ranging from once daily to several times daily. Application is generally based on the individual's need for symptomatic support, allowing for intermittent or continuous use as required.


Q: What happens if I miss a typical application of Panthoderm Cream?

A: Since the recommended frequency is often flexible and 'as needed,' structured dosing guidance suggests applying the missed dose as soon as it is remembered. If it is nearly time for the next typical application, the missed application is typically skipped, and the individual continues with the pattern of application that is generally followed.


Q: Can Panthoderm Cream be used alongside prescribed steroid creams?

A: Official regulatory documents consistently state that no drug interactions have been reported for the topical Panthoderm Cream formulation. The absence of documented interactions for this topical product is consistent across international regulatory bodies.


Q: Can I apply other lotions right after using Panthoderm Cream?

A: Regulatory documents do not report any drug-to-drug interactions for the topical formulation. The sequencing of other non-drug, non-interacting cosmetic products is not specified by regulatory documents and may be guided by the individual's preference.


Q: Is it okay to apply Panthoderm Cream to broken skin?

A: The cream is intended strictly for external, dermal use. Official information regarding emollients suggests that use on severe cuts, infections, or sores may require guidance from a healthcare professional. The cream's purpose is associated with supporting re-epithelialization and skin integrity.


Q: Does Panthoderm Cream have any known systemic absorption effects?

A: Upon topical application, the active ingredient is absorbed into the skin cells, where it is converted to pantothenic acid. The topical formulation is consistently described in official documents as having low systemic absorption. The low systemic absorption minimizes the potential for systemic drug interactions, which is characteristic of topical agents.


Q: Are there any known issues with using Panthoderm Cream while breastfeeding?

A: Use during lactation is generally permitted but requires caution. Regulatory information indicates that if the cream is applied to the breast area, thorough cleansing is required before each subsequent nursing session to help prevent unintentional exposure to the infant.


Q: Has Panthoderm Cream been studied in pregnant women?

A: The product is classified by some authorities under Pregnancy Category C, which signifies that human studies are either not available or neither animal nor human studies have been done. The classification indicates that use during pregnancy is conditional and requires caution.


Q: Are there any reported long-term effects of using Panthoderm Cream?

A: The safety profile is defined by documented acute and serious adverse events. Regulatory-reviewed evidence summaries note that research studies largely focus on acute, short-term use and that comprehensive long-term data extending beyond the typical follow-up periods are not widely available.


Q: Does using Panthoderm Cream prevent a skin condition from coming back?

A: Official research evidence examines the cream as a supportive or adjuvant therapy for maintaining skin health. Research typically focuses on its role in supporting the skin barrier function and integrity, which are elements necessary for a skin condition's maintenance phase.


Q: Is it normal to feel a slight tingling sensation when first using Panthoderm Cream?

A: Official regulatory documents list tingling (paresthesia) as a common, expected dermal effect. Other common, mild effects listed include localized irritation, rash, and itching.


Q: What should I do if I accidentally get Panthoderm Cream in my eyes?

A: Official instructions mandate strict avoidance of contact with the eyes. General guidance for accidental topical exposure often includes rinsing the affected eye thoroughly with water; seeking professional assistance is indicated if irritation persists.


Q: What is the purpose of the inactive ingredients in Panthoderm Cream?

A: The cream's formulation is centered on the active ingredient Dexpanthenol and various topical emollients. These inactive emollients are intended to soften and moisturize the skin and help trap water in the skin’s upper layer, complementing the cellular support provided by the active ingredient.


Q: Is Panthoderm Cream officially described as 'all-natural'?

A: The active ingredient Dexpanthenol is chemically described in official sources as an alcoholic derivative and synthetic analogue of pantothenic acid (Vitamin B5). The product's composition is centered on this derived substance and various topical emollients.


Q: What skin conditions is Panthoderm Cream NOT intended to treat?

A: Official labeling defines the conditions the cream is indicated to treat, such as supporting the skin barrier and managing dry skin. It is not officially indicated for use as a primary treatment for severe, chronic, or systemic skin disorders, or for skin infections.


Q: Is the research on Panthoderm Cream considered conclusive?

A: Authoritative summaries of the research base note that studies use strong methodologies, such as randomized controlled trials, to examine aspects like barrier function and hydration. However, these same summaries often note limitations, such as limited long-term data or challenges in isolating the cream's full contribution when used as an adjuvant therapy.


Q: What is the difference between Panthoderm Cream and Panthoderm Ointment?

A: Both the cream and the ointment forms contain the same active ingredient, Dexpanthenol. The difference lies in the base: creams are oil-in-water emulsions, which are typically lighter and absorb faster, whereas ointments are generally greasier, water-in-oil formulations that provide a more occlusive barrier.


Q: What is the consistency of Panthoderm Cream like?

A: The Panthoderm product is a cream formulation, which is an oil-in-water emulsion. Creams are generally described in official dosage form documents as lighter than ointments, designed to be quickly absorbed into the skin without leaving a heavy or greasy residue.

Advertisements

How should Panthoderm Cream be stored and disposed of?

How to Store and Dispose of Panthoderm Cream?

The official regulatory labeling for Dexpanthenol topical preparations dictates specific requirements for product stability and safety.

Storage Requirements

Condition Requirement
Temperature Store at a temperature below 30 C.
Handling Keep the container tightly closed and in its original packaging.
Stability Do not use the cream after the expiration date printed on the label.
Child Safety Keep out of reach of children. Seek medical help immediately if swallowed.

Disposal Instructions

Unused or expired cream must be disposed of according to local regulations. The preferred method is to utilize a community drug take-back program. If a take-back option is unavailable, the product may be mixed with an undesirable substance and sealed before being placed in the household trash. Do not pour the cream down any drain or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Panthoderm Cream found in:

A-Z Index: